Showing 121-130 of 1354 results for "".
Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.Immunopathogenesis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/immunopathogenesis-of-multiple-sclerosis/30127/Disruption of immune tolerance, inflammation, and blood-brain–barrier breach lead to demyelination and axonal injury.Update on Treating Sleep Disorders
https://practicalneurology.com/diseases-diagnoses/sleep/update-on-treating-sleep-disorders/30114/New treatments hold promise of increasing efficacy with precision medicine.Epilepsy Essentials: Seizure Disorders and Commercial Motor Vehicle Operators
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-seizure-disorders-and-commercial-motor-vehicle-operators/30858/Clinical neurologists should be familiar with regulations regarding commercial drivers' qualifications to drive and the role of third party examiners.Novel Treatments for Alzheimer Disease Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/novel-treatments-for-alzheimer-disease-disorders/31801/A selection of drugs currently in clinical trials organized by Common Alzheimer Disease Research Ontology focused on mechanisms of action.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Dystonia Treatment: Current Approach and Future Directions
https://practicalneurology.com/diseases-diagnoses/movement-disorders/dystonia-treatment-current-approach-and-future-directions/32168/The management of dystonia requires a multifacted approach designed to alleviate symptoms, improve functional capacity, and enhance overall quality of life.Spontaneous Intracranial Hemorrhage Secondary to Rare Pial Arteriovenous Fistula Rupture
https://practicalneurology.com/diseases-diagnoses/stroke/spontaneous-intracranial-hemorrhage-secondary-to-rare-pial-arteriovenous-fistula-rupture/35445/Pial arteriovenous fistulas are rare cerebrovascular malformations most commonly seen in children; however, they can be found in adults, especially in the setting of an intracranial hemorrhage.Reversible Cortical Blindness Secondary to Acute Carbon Monoxide Poisoning
https://practicalneurology.com/diseases-diagnoses/neuromuscular/reversible-cortical-blindness-secondary-to-acute-carbon-monoxide-poisoning/32156/We present a case of acute cortical blindness in the setting of carbon monoxide poisoning that reversed with hyperbaric oxygen therapy.An Update on Nutraceuticals for Migraine Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-nutraceuticals-for-migraine-management/32132/Many people with migraine use integrative modalities, including nutraceutical supplements, along with mainstream medicine for disease control.